| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/29/2010 | WO2010011772A3 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 04/29/2010 | WO2010009091A3 Anti-inflammatory and anti-allergy extracts from nettle |
| 04/29/2010 | WO2010007316A3 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/29/2010 | WO2010006129A3 2-methylene-(22e)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
| 04/29/2010 | WO2010003120A3 Antagonists of prostaglandin d2 receptors |
| 04/29/2010 | WO2009149382A3 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells |
| 04/29/2010 | WO2009143457A3 Vaccine composition containing synthetic adjuvant |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105896 Pharmaceutical compounds |
| 04/29/2010 | US20100105777 Amide or thioamide derivatives and their use in the treatment of pain |
| 04/29/2010 | US20100105770 Therapeutic delivery of carbon monoxide |
| 04/29/2010 | US20100105767 Compounds, compositions and methods |
| 04/29/2010 | US20100105723 5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS |
| 04/29/2010 | US20100105721 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS |
| 04/29/2010 | US20100105717 Tacrolimus for improved treatment of transplant patients |
| 04/29/2010 | US20100105696 IMIDAZOQUINOLINES AS DUAL LIPID KINASE AND mTOR INHIBITORS |
| 04/29/2010 | US20100105692 Dipterinyl Calcium Pentahydrate (DCP) and Therapeutic Methods Based Thereon |
| 04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 04/29/2010 | US20100105676 Fused heterocyclic compounds useful as kinase modulators |
| 04/29/2010 | US20100105660 Organic compounds75074 |
| 04/29/2010 | US20100105630 Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders |
| 04/29/2010 | US20100105602 Treatment of intracellular bacterial infections |
| 04/29/2010 | US20100104668 Nutritional supplement for honeybees |
| 04/29/2010 | US20100104632 Drug Having Regulatory Cell Ligand Contained in Liposome |
| 04/29/2010 | US20100104606 Allergen fragments |
| 04/29/2010 | US20100104603 Use of staphylococcal superantigen-like protein 5 (ssl5) in medicine |
| 04/29/2010 | US20100104601 Treatment of immune disease by mucosal delivery of antigents using genetically modified lactobacillus |
| 04/29/2010 | US20100104599 Compositions and Methods For Enhancing Immune System of Felines |
| 04/29/2010 | US20100104596 Acutte transmitted hiv envelope signatures |
| 04/29/2010 | US20100104595 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 04/29/2010 | US20100104594 Pathogen for bacterial poultry disease |
| 04/29/2010 | US20100104592 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/29/2010 | US20100104591 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 04/29/2010 | US20100104590 Alpha-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation method and pharmaceutical composition for the immune adjuvant containing the same as an active ingredient |
| 04/29/2010 | US20100104587 Methods of modulating the negative chemotaxis of immune cells |
| 04/29/2010 | US20100104581 Methods for Diagnosing and Treating Graft Rejection and Inflammatory Conditions |
| 04/29/2010 | US20100104579 Trex1 as a marker for lupus erythematosus |
| 04/29/2010 | US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 04/29/2010 | US20100104573 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
| 04/29/2010 | US20100104571 Antibody-mediated modulation of allergy |
| 04/29/2010 | US20100104569 Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104562 Enhancing Efficacy of Vaccines Administered Via the Respiratory Tract |
| 04/29/2010 | US20100104557 Optimized Antibodies that Target HM1.24 |
| 04/29/2010 | US20100104553 Antibodies and methods for making and using them |
| 04/29/2010 | US20100104543 Cellular compositions and methods of making and using them |
| 04/29/2010 | US20100104533 Early intervention of viral infection with immune activators |
| 04/29/2010 | US20100104507 Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo |
| 04/29/2010 | DE102009004436A1 Verwendung einer Tirucallensäure, einer Lupansäure oder einer Robursäure als Arzneimittel Using a Tirucallensäure, a Lupansäure or Robur acid as a drug |
| 04/29/2010 | CA2741333A1 Vaccine against african horse sickness virus |
| 04/29/2010 | CA2740857A1 Composition for targeting dendritic cells |
| 04/29/2010 | CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740313A1 Crystalline forms of (r) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [z] ylidene] -2- ( [z] -propylimino) -3-0-tolyl-thiazolidin-4-one |
| 04/29/2010 | CA2739882A1 Pharmaceutical composition improving intestinal absorption |
| 04/29/2010 | CA2735956A1 Phosphodiestarase inhibitors |
| 04/28/2010 | EP2179984A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 04/28/2010 | EP2179742A1 Compositions and methods for the treatment of immune related diseases |
| 04/28/2010 | EP2179039A2 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 04/28/2010 | EP2178920A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178919A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178918A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178874A1 Heterocyclic compounds useful as mk2 inhibitors |
| 04/28/2010 | EP2178840A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 04/28/2010 | EP2178522A1 Compressed chewing gum tablet comprising taste-masking agent |
| 04/28/2010 | EP1827138B1 DRY CONCENTRATE FOR MAKING DIETETIC SOFT DRINK CONTAINING Fe, BEE BREAD AND VITAMIN C AND ITS PRODUCTION PROCESS |
| 04/28/2010 | EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 04/28/2010 | EP1581532B1 Pyrazolo¬3,4-b pyridine compounds, and their use as phosphodiesterase inhibitors |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | CN1923241B Medicine composition containing epimedium extract, uncaria extract, and gastrodine, and its preparation and use |
| 04/28/2010 | CN1902352B Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 04/28/2010 | CN1895498B Health-care bee products mixed with Chinese yam |
| 04/28/2010 | CN1860228B Staple type oligonucleotide and drug comprising the same |
| 04/28/2010 | CN1809586B Biologically active peptide comprising tyrosyl-seryl-valine (YSV) |
| 04/28/2010 | CN1798762B Tuberculosis vaccine with improved efficacy |
| 04/28/2010 | CN1777673B Treatment of IgA1 deposition diseases |
| 04/28/2010 | CN1700917B Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 04/28/2010 | CN1678333B Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease |
| 04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/28/2010 | CN1658855B O-substituted hydroxyaryl derivatives |
| 04/28/2010 | CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine, |
| 04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
| 04/28/2010 | CN101698852A Protein or polypeptide with function of CD137L, and gene and application thereof |
| 04/28/2010 | CN101698816A Coix seed wine and coix seed ginseng root wine |
| 04/28/2010 | CN101698098A Preparation method of sustained release preparation of phytohemagglutinin |
| 04/28/2010 | CN101698089A Traditional Chinese medicine volatile oil clathrate compound and preparation method thereof |
| 04/28/2010 | CN101698077A Healthy carry-on bag |
| 04/28/2010 | CN101698041A Aloe vitamin C effervescent tablet |
| 04/28/2010 | CN101698000A Traditional Chinese medicine for treating allergic rhinitis |
| 04/28/2010 | CN101697996A Chinese herbal medicinal composition for externally treating allergic rhinitis |
| 04/28/2010 | CN101697981A Fast, non-heat change and high-efficiency method for breaking ganoderma lucidum spore |
| 04/28/2010 | CN101697980A Balance-element health-care capsules |
| 04/28/2010 | CN101697979A Officinal fungus mycelium extract and preparation method thereof |
| 04/28/2010 | CN101697975A GSLS tablets used for animals and poultries and preparation method thereof |
| 04/28/2010 | CN101697974A GSLS capsules used for animals and poultries and preparation method thereof |
| 04/28/2010 | CN101014560B Wikstroemia indeca extract, their production and use in the production of anti-inflammatory pharmaceutical |
| 04/27/2010 | USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors |
| 04/27/2010 | US7705125 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/27/2010 | US7705124 Leucine-based motif and clostridial neurotoxins |
| 04/27/2010 | US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases |